Joel Greenblatt - Gotham Asset Management
Holding/activity history for Roivant Sciences Ltd. (ROIV)
← All ROIV superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,416,091 | 0.12 | Add 53.06% | 0.04 | $20.78–30.33 · VW $25.87i | $39,225,721 | SEC |
| 2025 Q4 | 925,193 | 0.07 | Add 179.96% | 0.05 | $15.25–23.47 · VW $20.09i | $20,076,688 | SEC |
| 2025 Q3 | 330,475 | 0.02 | Add 744.15% | 0.02 | $10.70–16.19 · VW $13.10i | $5,000,087 | SEC |
| 2025 Q2 | 39,149 | <0.01 | Add 0.31% | $8.73–11.81 · VW $10.90i | $441,209 | SEC | |
| 2025 Q1 | 39,027 | <0.01 | $10.09 | $393,782 | SEC | ||
| 2024 Q4 | 39,027 | <0.01 | $11.83 | $461,689 | SEC | ||
| 2024 Q3 | 39,027 | <0.01 | Reduce 1.29% | <0.01 | $10.00–13.06 · VW $11.55i | $450,372 | SEC |
| 2024 Q2 | 39,537 | <0.01 | Buy | <0.01 | $10.15–11.80 · VW $10.93i | $417,906 | SEC |
Price snapshot:
Current price$34.51
Avg. buy price$22.12
+/- since buy56.01%
52-week low$10.90
52-week high$37.00